يعرض 1 - 10 نتائج من 11 نتيجة بحث عن '"Margriet Oosterveld"', وقت الاستعلام: 0.87s تنقيح النتائج
  1. 1
  2. 2
    دورية أكاديمية
  3. 3
  4. 4

    المساهمون: Hematology, Interne Geneeskunde, MUMC+: MA Hematologie (9), RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy, Medical and Clinical Psychology

    المصدر: Journal of Medical Internet Research, 23
    Journal of Medical Internet Research, 23(12):e27886. Journal of medical Internet Research
    Journal of Medical Internet Research
    Journal of Medical Internet Research, 23, 12
    Journal of Medical Internet Research, 23(12):e27886. JMIR Publications Inc.
    Oerlemans, S, Arts, L P J, Kieffer, J M, Prins, J, Hoogendoorn, M, van der Poel, M, Koster, A, Lensen, C, Stevens, W B C, Issa, D, Pruijt, J F M, Oosterveld, M, van der Griend, R, Nijziel, M, Tick, L, Posthuma, E F M & van de Poll-Franse, L V 2021, ' Web-Based Return of Individual Patient-Reported Outcome Results among Patients with Lymphoma : Randomized Controlled Trial ', Journal of Medical Internet Research, vol. 23, no. 12, e27886 . https://doi.org/10.2196/27886
    Journal of Medical Internet Research, 23(12):e27886. JMIR PUBLICATIONS, INC

    وصف الملف: application/pdf

  5. 5
  6. 6

    المساهمون: UCL - (SLuc) Service d'hématologie, UCL - (SLuc) Centre du cancer, UCL - SSS/IREC/SLUC - Pôle St.-Luc, UCL - SSS/IREC/MONT - Pôle Mont Godinne, UCL - (MGD) Service d'hématologie, Internal medicine, VU University medical center, Hematology laboratory, CCA - Cancer Treatment and quality of life, RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy, Interne Geneeskunde, MUMC+: MA Hematologie (9), Graduate School, Clinical Haematology, CCA - Cancer Treatment and Quality of Life, Stem Cell Aging Leukemia and Lymphoma (SALL), Guided Treatment in Optimal Selected Cancer Patients (GUTS), Hematology, Orthopedics and Sports Medicine

    المصدر: Cancers, vol. 13, no. 4, pp. 672
    Cancers, Vol. 13, No 4 (2021) P. 672
    Cancers
    Volume 13
    Issue 4
    Cancers, 13
    Janssen, J, Löwenberg, B, Manz, M, Bargetzi, M, Biemond, B, von dem Borne, P, Breems, D, Brouwer, R, Chalandon, Y, Deeren, D, Efthymiou, A, Gjertsen, B T, Graux, C, Gregor, M, Heim, D, Hess, U, Hoogendoorn, M, Jaspers, A, Jie, A, Jongen-Lavrencic, M, Klein, S, van der Klift, M, Kuball, J, van Lammeren-Venema, D, Legdeur, M C, van de Loosdrecht, A, Maertens, J, Kooy, M V M, Moors, I, Nijziel, M, van Obbergh, F, Oosterveld, M, Pabst, T, van der Poel, M, Sinnige, H, Spertini, O, Terpstra, W, Tick, L, van der Velden, W, Vekemans, M C, Vellenga, E, de Weerdt, O, Westerweel, P, Stüssi, G, van Norden, Y & Ossenkoppele, G 2021, ' Inferior outcome of addition of the aminopeptidase inhibitor tosedostat to standard intensive treatment for elderly patients with aml and high risk mds ', Cancers, vol. 13, no. 4, 672, pp. 1-11 . https://doi.org/10.3390/cancers13040672
    Cancers, Vol. 13, no. 4, p. 672 [1-11] (2021)
    Cancers, Vol 13, Iss 672, p 672 (2021)
    Cancers, 13(4):672, 1-11. Multidisciplinary Digital Publishing Institute (MDPI)
    Janssen, Jeroen; Löwenberg, Bob; Manz, Markus; Bargetzi, Mario; Biemond, Bart; Borne, Peter von dem; Breems, Dimitri; Brouwer, Rolf; Chalandon, Yves; Deeren, Dries; Efthymiou, Anna; Gjertsen, Bjørn-Tore; Graux, Carlos; Gregor, Michael; Heim, Dominik; Hess, Urs; Hoogendoorn, Mels; Jaspers, Aurelie; Jie, Asiong; Jongen-Lavrencic, Mojca; ... (2021). Inferior Outcome of Addition of the Aminopeptidase Inhibitor Tosedostat to Standard Intensive Treatment for Elderly Patients with AML and High Risk MDS. Cancers, 13(4) MDPI AG 10.3390/cancers13040672 <http://dx.doi.org/10.3390/cancers13040672>
    Cancers, 13, 4
    Cancers, 13(4):672. Multidisciplinary Digital Publishing Institute (MDPI)
    Cancers, 13(4):672. MDPI AG
    CANCERS

    وصف الملف: application/pdf; Electronic

  7. 7

    المساهمون: UCL - (SLuc) Centre du cancer, UCL - SSS/IREC/SLUC - Pôle St.-Luc, UCL - (SLuc) Service d'hématologie, Internal medicine, Hematology, CCA - Cancer Treatment and quality of life

    المصدر: Journal of clinical oncology, Vol. 39, no. 25, p. 2758-2767 (2021)
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 39(25), 2758-2767. American Society of Clinical Oncology
    Stege, C A M, Nasserinejad, K, van der Spek, E, Bilgin, Y M, Kentos, A, Sohne, M, van Kampen, R J W, Ludwig, I, Thielen, N, Durdu-Rayman, N, de Graauw, N C H P, van de Donk, N W C J, de Waal, E G M, Vekemans, M C, Timmers, G J, van der Klift, M, Soechit, S, Geerts, P A F, Silbermann, M H, Oosterveld, M, Nijhof, I S, Sonneveld, P, Klein, S K, Levin, M D & Zweegman, S 2021, ' Ixazomib, Daratumumab, and Low-Dose Dexamethasone in Frail Patients With Newly Diagnosed Multiple Myeloma : The Hovon 143 Study ', Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol. 39, no. 25, pp. 2758-2767 . https://doi.org/10.1200/JCO.20.03143

  8. 8
  9. 9

    المساهمون: Medical and Clinical Psychology

    المصدر: Journal of Medical Internet Research
    Journal of Medical Internet Research, Vol 22, Iss 5, p e17018 (2020)
    Journal of Medical Internet Research (JMIR), 22(5):e17018. JMIR PUBLICATIONS, INC

    وصف الملف: application/pdf

  10. 10